New work from our lab @faurelab.bsky.social expending the tools available to study nicotinic receptors more precisely. @espciparispsl.bsky.social @psl-univ.bsky.social
Institut Pasteur researchers developed "optonanobody": a light-controlled nanobody targeting α7 nicotinic receptors. Switch receptors on/off with light, no genetic editing needed. New research tool for Alzheimer's, Parkinson's & schizophrenia. #Neuroscience ↘️ pubs.acs.org/doi/10.1021/...